Literature DB >> 16862462

The absence of dyspnoea, cough and wheezing: a reason for undiagnosed airflow obstruction?

Gérald d'Andiran1, Christian Schindler, Philippe Leuenberger.   

Abstract

OBJECTIVES: The diagnosis of obstructive lung disease (OLD) may be overlooked because of the poor correlation between the intensity of symptoms and the severity of airway obstruction (AO). Undiagnosed airflow obstruction (UDAO) is associated with health impairment and mortality. Questions remain such as the reasons for its occurrence and the underlying diseases. In a pulmonologist's private practice, the objectives were to detect UDAO in the absence of dyspnoea, cough and wheezing, to improve its screening following other anamnestic data, and to separate UDAO patients into "silent asthma" (SA) or "persistent obstruction".
METHODS: Patients were subjected to a verbal questionnaire for the detection of alternative indication for pulmonary function tests (PFTs), to a physical examination and, in the case of a severe smoking habit, to a chest X-ray. PFTs were performed whenever an OLD history or another lung disease was present and, in the absence of any dyspnoea, cough and wheezing, when other symptoms and conditions occurred (sputum, chest tightness, fatigue, rhinitis, snoring; active/passive smoking, recurrent lower respiratory tract infections, asthma in childhood or in family, atopy).
RESULTS: Of 3762 consecutive patients, 1389 patients with AO were identified. Among them, 147 UDAO patients were detected with no history of dyspnoea, cough and wheezing (3.9% and 10.6%, respectively). All these patients had other suggestive symptoms and AO risk factors which justified PFTs. They presented with mild (65%), moderate (21%) or even severe (16%) AO. SA patients normalized their spirometric values under treatment.
CONCLUSION: The absence of dyspnoea, cough and wheezing is a fairly frequent finding and a reason for UDAO. PFTs are warranted with any suggestive symptoms and AO risk factors. The favourable follow-up underlines the importance of screening for UDAO.

Entities:  

Mesh:

Year:  2006        PMID: 16862462     DOI: 2006/27/smw-11128

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  2 in total

1.  Differing reports of asthma symptoms in African Americans and Caucasians.

Authors:  D Scott Trochtenberg; Rhonda BeLue; Sharon Piphus; Niketa Washington
Journal:  J Asthma       Date:  2008-03       Impact factor: 2.515

Review 2.  Early management of COPD: where are we now and where do we go from here? A Delphi consensus project.

Authors:  Fabiano Di Marco; Piero Balbo; Francesco de Blasio; Vittorio Cardaci; Nunzio Crimi; Giuseppe Girbino; Girolamo Pelaia; Pietro Pirina; Pietro Roversi; Pierachille Santus; Nicola Scichilone; Alessandro Vatrella; Patrizio Pasqualetti; Mauro Carone
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-02-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.